Extrait

to assess the predictive power of in-silico evaluation of glycemic control with exenatide and insulin glargine

Critère d'inclusion

• the trial will be performed in a total of 58 male and female patients with type 2 diabetes who will be assigned to two groups, receiving either exenatide or insulin glargine

Liens

• euctr
• ictrp